"Hepatitis B Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
| Descriptor ID |
D006510
|
| MeSH Number(s) |
D12.776.124.486.485.114.254.450.504 D12.776.124.790.651.114.254.450.504 D12.776.377.715.548.114.254.450.504
|
| Concept/Terms |
Hepatitis B Antibodies- Hepatitis B Antibodies
- Antibodies, Hepatitis B
- B Antibodies, Hepatitis
- Anti-Australia Antigens
- Anti Australia Antigens
- Antigens, Anti-Australia
- Anti-Hepatitis B Antigens
- Anti Hepatitis B Antigens
- Antigens, Anti-Hepatitis B
- B Antigens, Anti-Hepatitis
- Hepatitis B Virus Antibodies
- Anti HBAg
- HBAg, Anti
- Anti-HBAg
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B Antibodies".
This graph shows the total number of publications written about "Hepatitis B Antibodies" by people in this website by year, and whether "Hepatitis B Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 13 | 21 | 34 |
| 2018 | 16 | 11 | 27 |
| 2019 | 5 | 6 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis B Antibodies" by people in Profiles.
-
Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacy. Hum Vaccin Immunother. 2021 11 02; 17(11):4578-4586.
-
Retrained Generic Antibodies Can Recognize SARS-CoV-2. J Phys Chem Lett. 2021 Feb 11; 12(5):1438-1442.
-
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment. Dig Dis Sci. 2021 11; 66(11):4026-4034.
-
Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy. J Viral Hepat. 2021 01; 28(1):89-94.
-
Occult hepatitis B and HIV infection. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1403-1407.
-
Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response. Front Immunol. 2019; 10:2308.
-
Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV). Viruses. 2019 09 13; 11(9).
-
New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts. Viruses. 2019 08 25; 11(9).
-
Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic. BMC Infect Dis. 2019 Jun 10; 19(1):507.
-
Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening. Medicine (Baltimore). 2019 May; 98(18):e15412.